Menuka Karki

6PUBLICATIONS
82CO-AUTHORS
Molecular targetsPredictive and prognostic markersCentral nervous systemMedical biochemistry - proteins and peptides (incl. medical proteomics)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 20, 2026
Phase II Trial of Ixazomib Combined with Gemcitabine and Doxorubicin in Patients with SMARCB1-Deficient Renal Medullary Carcinoma.

|Jul 02, 2025
Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.

Niki M Zacharias, Manuel Ozambela, Menuka Karki

|Jan 21, 2025
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.

Sandra L Grimm, Menuka Karki, Kyle A Blum

|Sep 02, 2022
CIC missense variants contribute to susceptibility for spina bifida.

Xiao Han, Xuanye Cao, Vanessa Aguiar-Pulido

|Apr 03, 2021
A cytoskeletal function for PBRM1 reading methylated microtubules.

Menuka Karki, Rahul K Jangid, Ramakrishnan Anish

|Oct 03, 2020
The Huntingtin-interacting protein SETD2/HYPB is an actin lysine methyltransferase.

Riyad N H Seervai, Rahul K Jangid, Menuka Karki

Pageof 1

Frequent Collaborators

4 joint publications

Pavlos Msaouel

3 joint publications

Nizar M Tannir

3 joint publications

Durga Nand Tripathi

3 joint publications

Priya Rao